Sign in

CIK 0001125345

  • Non-accelerated filer
  • Smaller reporting company

MACROGENICS INC

Sign in to watch
Ticker
MGNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-251-5172
Business address
9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-01-16 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Exercise or conversion +2,476 $4.70 $12K 32,476
2018-01-16 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Sale −2,476 $20.00 $50K 30,000
2018-01-16 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Exercise or conversion · Employee stock option (right to buy) −2,476 47,972
2017-12-29 Karrels James SVP, CFO and Secretary Exercise or conversion +3,000 $0.94 $3K 113,331
2017-12-29 Karrels James SVP, CFO and Secretary Exercise or conversion · Employee stock option (right to buy) −3,000 6,516
2017-11-21 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Exercise or conversion +5,000 $4.70 $24K 35,000
2017-11-21 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Sale −5,000 $20.00 $100K 30,000
2017-11-21 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Exercise or conversion · Employee stock option (right to buy) −5,000 50,448
2017-11-13 SIEGEL JAY PHILIP Director Grant or award · Stock Option (right to buy) +20,000 20,000
2017-10-25 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Exercise or conversion +10,000 $4.70 $47K 40,000
2017-10-25 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Sale −10,000 $20.00 $200K 30,000
2017-10-25 Wigginton Jon Marc Sr VP, Clinical Dev. & CMO Exercise or conversion · Employee stock option (right to buy) −10,000 $4.70 $47K 55,448
2017-09-05 Karrels James SVP, CFO and Secretary Exercise or conversion +5,000 $0.94 $5K 110,331
2017-09-05 Karrels James SVP, CFO and Secretary Exercise or conversion · Employee stock option (right to buy) −5,000 9,516
2017-09-05 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion +2,000 $0.94 $2K 6,000
2017-09-05 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion · Employee stock option (right to buy) −2,000 31,497
2017-07-26 Bonvini Ezio Sr VP, Research & CSO Exercise or conversion +26,632 $1.51 $40K 120,026
2017-07-26 Bonvini Ezio Sr VP, Research & CSO Exercise or conversion +26,632 $0.94 $25K 146,658
2017-07-26 Bonvini Ezio Sr VP, Research & CSO Exercise or conversion · Employee stock option (right to buy) −26,632 $1.51 $40K 0
2017-07-26 Bonvini Ezio Sr VP, Research & CSO Exercise or conversion · Employee stock option (right to buy) −26,632 $0.94 $25K 0

Page 34 of 35 · 684 trades